Back to search
Non-Small Cell Carcinoma of Lung, TNM Stage 4
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Small Cell Carcinoma of Lung, TNM Stage 4 trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Small Cell Carcinoma of Lung, TNM Stage 4 trials you may qualify forA comparison of baseline tumor characteristics in oncogene-driven cancers to tumor characteristics after early response to Tyrosine Kinase Inhibitor (TKI) targe…
While cigarette smoking remains the primary cause of most lung cancer cases, lung carcinoma in never smokers account for nearly 20 percent of cases. Never smoke…
Overall survival (OS) of patients with advanced (stage IIIB/IV) non-small-cell lung cancer (NSCLC) remains short after the first line of treatment with a median…
This study will evaluate the safety and tolerability of LYL797, a ROR1-targeted CAR T-cell therapy, in patients with ROR1+ relapsed or refractory triple negativ…
Biomarker Screening Protocol for Preliminary Eligibility Determination for Adoptive T-cell Therapy Trials:This is a decentralized, multi-site, US-based biomarke…